Mean ± SD | All | High dose | Low dose | Sham |
---|---|---|---|---|
N (F) | 30 (13) | 10 (2) | 10 (7) | 10 (4) |
Age | 58 ± 8 | 60 ± 9 | 58 ± 8 | 54 ± 7 |
Duration (treated knee, years)* | 11 ± 8 | 10 ± 7 | 6 ± 6 | 16 ± 8 |
Pain | ||||
 Baseline | 56 ± 14 | 59 ± 13 | 53 ± 9 | 56 ± 19 |
 Post-treatment | 64 ± 14 | 70 ± 16 | 66 ± 11 | 56 ± 12 |
Symptoms | ||||
 Baseline | 53 ± 16 | 57 ± 19 | 48 ± 11 | 54 ± 18 |
 Post-treatment | 58 ± 15 | 60 ± 20 | 58 ± 15 | 55 ± 11 |
Adjusted daily living | ||||
 Baseline | 64 ± 15 | 66 ± 12 | 61 ± 14 | 64 ± 20 |
 Post-treatment | 72 ± 16 | 74 ± 18 | 76 ± 12 | 65 ± 15 |
Function in sport | ||||
 Baseline | 30 ± 23 | 30 ± 18 | 31 ± 19†| 29 ± 31 |
 Post-treatment | 41 ± 26 | 49 ± 33 | 48 ± 18 | 28 ± 21 |
Quality of life | ||||
 Baseline | 39 ± 15 | 42 ± 17 | 38 ± 14 | 36 ± 16 |
 Post-treatment | 38 ± 18 | 44 ± 20 | 41 ± 16 | 29 ± 17 |